Rahila S. Khwaja

Rahila Khwaja practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Rahila Khwaja's NPI, 1356396097, was assigned on May 23, 2006. Rahila Khwaja holds Pennsylvania license MD044663L.

Rahila Khwaja's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Rahila Khwaja's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Rahila Khwaja is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is Stull, Jarvis, and Spinola Internal Medicine Associates-UPMC. Dmand AI also links Rahila Khwaja to 5 more hospitals, 2 group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rahila Khwaja practices, 11 sites in all. Vendor and product names are available with a free account.

Internal medicine is Rahila Khwaja's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Rahila Khwaja is licensed in Pennsylvania.

CMS data shows 415 Medicare services from Rahila Khwaja across 6 procedure codes in 2024, for 181 Medicare patients. Medicare paid $23,742 for them. Every service was in an office.

CMS counts 181 Medicare patients who saw Rahila Khwaja in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Rahila Khwaja's median patient age at 73, with 70% women.

In 2024, Rahila Khwaja wrote 12,531 Medicare Part D claims for 834 patients. 88% of them were for generic drugs. CMS names the drug for 11,853 of them, across 153 drugs with 11 or more claims each, at $1,054,046 in total drug cost. In 2023, CMS named 10,166 claims across 130 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Rahila Khwaja for performance year 2024, reported as part of a group. Rahila Khwaja accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rahila Khwaja as offering telehealth.

CMS Open Payments shows 8 general payments to Rahila Khwaja from 4 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $74.